4:30 PM ET
8-K
Regulatory Approval
HeartSciences Regulatory Approval
HeartSciences received FDA 510(k) clearance for its MyoVista wavECG device as a 12-lead resting electrocardiograph for adult and pediatric patients. While the company does not intend to commercialize the device without a cleared AI-ECG algorithm, the approval broadens strategic options for the asset and its intellectual property. The company also noted its pending merger with Fortitude Mining Holdings remains on track to close in Q4 2026.